203 related articles for article (PubMed ID: 23971526)
1. Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus.
Ma D; Chen C; Lu Y; Ma J; Yin P; Xie J; Yang Y; Shao S; Liu Z; Zhou X; Yuan G; Yu X
Diabetes Technol Ther; 2013 Dec; 15(12):1010-8. PubMed ID: 23971526
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion reduces the risk of postoperative infection.
Mou Y; Ma D; Zhang J; Tao J; He W; Li W; Mu Y; Yu X
J Diabetes; 2020 May; 12(5):396-405. PubMed ID: 31697444
[TBL] [Abstract][Full Text] [Related]
3. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions.
Corney SM; Dukatz T; Rosenblatt S; Harrison B; Murray R; Sakharova A; Balasubramaniam M
J Diabetes Sci Technol; 2012 Sep; 6(5):1003-15. PubMed ID: 23063025
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
5. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
6. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
7. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
8. The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis.
Sharma D; Morrison G; Joseph F; Purewal TS; Weston PJ
Diabetologia; 2011 Nov; 54(11):2768-70. PubMed ID: 21842427
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
[No Abstract] [Full Text] [Related]
10. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
13. Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus.
Song W; Wen J; Zhang J; Luo M; Hu Y; Zhang Y; Fan G; Zhao L
J Diabetes Res; 2023; 2023():8542262. PubMed ID: 37396491
[TBL] [Abstract][Full Text] [Related]
14. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
[TBL] [Abstract][Full Text] [Related]
15. Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients: basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment.
Zeng L; Lu H; Deng H; Mu P; Li X; Wang M
Diabetes Technol Ther; 2012 Jan; 14(1):35-42. PubMed ID: 21877913
[TBL] [Abstract][Full Text] [Related]
16. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.
Liu J; Liu J; Fang D; Liu L; Huang Z; Wan X; Cao X; Li Y
Endocr J; 2013; 60(6):725-32. PubMed ID: 23428844
[TBL] [Abstract][Full Text] [Related]
18. Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.
Ruan Y; Zhong J; Chen R; Zhang Z; Liu D; Sun J; Chen H
J Diabetes Res; 2021; 2021():5551216. PubMed ID: 34136580
[TBL] [Abstract][Full Text] [Related]
19. Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI).
Derosa G; Maffioli P; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Mereu R; Gravina A; Palumbo I; Randazzo S; Cicero AF
Endocr J; 2009; 56(4):571-8. PubMed ID: 19352055
[TBL] [Abstract][Full Text] [Related]
20. [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes].
Li YB; Zhu HL; Yao B; Huang ZM; Ou XZ; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):602-5. PubMed ID: 15949356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
